Unique Ingredient Identifier Q662QK8M3B is listed as a ingredient substance
| RN | 25322-68-3 |
| NCIT | C84088 |
| RXCUI | 1307312 |
| MF | Polymer substance not supported |
UNII Q662QK8M3B POLYETHYLENE GLYCOL 8000 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| OPHTHALMIC | SOLUTION | 2 % |
| ORAL | CAPSULE | 35 MG |
| ORAL | CAPSULE, DELAYED ACTION | 1.78 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 4.91 MG |
| ORAL | CAPSULE, HARD GELATIN | 27.8 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 1.39 MG |
| ORAL | TABLET | 400 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 5.71 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 6.5 MG |
| ORAL | TABLET, COATED | 0.21 MG |
| ORAL | TABLET, DELAYED ACTION | 3.17 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.75 MG |
| ORAL | TABLET, EXTENDED RELEASE | 144.6 MG |
| ORAL | TABLET, FILM COATED | 49 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 4.3 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 2.55 MG |
| ORAL | TABLET, SUSTAINED ACTION | 100 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 14 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.18 MG |
| RECTAL | SUPPOSITORY | 52 MG |
| SUBLINGUAL | FILM | 12.2 mg |
| TOPICAL | CREAM | 4.6 %W/W |
| TOPICAL | CREAM | 4 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 4 %W/W |
| TOPICAL | EMULSION, CREAM | 5 %W/W |
| TOPICAL | POWDER | NA |
| TOPICAL | SOLUTION | NA |
| VAGINAL | TABLET | 3 MG |